Promoting innovative pipelines and drug products of 에볼루션 바카라 사이트, 에볼루션 바카라 사이트lab, Pangen Biotech
[by Sung, Jae Jun] Huons USA, the U.S. sales arm of Huons Group, announced on May 26 that it had participated in the Convention on Pharmaceutical Ingredients Americas (CPHI Americas), held at the Pennsylvania Convention Center in Philadelphia. At the event, the company promoted the group’s drug products and innovative new drug candidate pipelines.
The CHPI Americas attracted tho에볼루션 바카라 사이트nds of attendees from more than 500 pharmaceutical companies, distributors, and R&D sectors from more than 50 countries worldwide.
에볼루션 바카라 사이트 USA showcased the group’s product portfolio focused on drug products and pipelines from 에볼루션 바카라 사이트, 에볼루션 바카라 사이트lab, and Pangen Biotech.
에볼루션 바카라 사이트 USA showcased 에볼루션 바카라 사이트’ famous injections and eye drops. 에볼루션 바카라 사이트’ recently FDA approved products, 1% and 2% 2mL multi-dose vials for lidocaine hydrochloride injection, received the spotlight at the convention.
에볼루션 바카라 사이트 USA introduced Pangen Biotech’s Erythropoietin (EPO) biosimilar, and its contract development and manufacturing organization (CDMO) business provided for biopharmaceuticals. 에볼루션 바카라 사이트 USA also highlighted 에볼루션 바카라 사이트lab’s proprietary platform technology under development. Also known as HyDIFFUZE™, it leverages recombinant human natural hyaluronidase to convert intravenous (IV) infusion to subcutaneous (SC) injection.
에볼루션 바카라 사이트 USA was actively engaged in business discussions and meetings with buyers and distributors from countries including Latin America, Middle East, Asia, and Africa.
CEO of 에볼루션 바카라 사이트 USA, Choi Jae-myung said, “We focused on raising the Group’s global presence and promoting brand competitiveness at CPHI Americas. We plan to engage in further discussions with buyers and distributors at the convention for exploring new business cooperation and export opportunities.”